PARDES BIOSCIENCES INC's ticker is and the CUSIP is 69945Q105. A total of 42 filers reported holding PARDES BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,809 | +36.9% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $1,321 | -21.8% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,690 | -15.5% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -57.1% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -56.2% | 1,000 | 0.0% | 0.00% | – |
| Q4 2021 | $16,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Opportunity Management V, LLC | 5,227,307 | $37,741,000 | 52.85% |
| Foresite Capital Management V, LLC | 9,400,515 | $67,872,000 | 27.72% |
| Lynx1 Capital Management LP | 1,642,834 | $11,861,000 | 11.01% |
| Frazier Life Sciences Management, L.P. | 2,081,007 | $15,025,000 | 1.28% |
| RA Capital Management | 6,175,038 | $44,584,000 | 0.97% |
| Arena Capital Advisors, LLC- CA | 851,281 | $6,146,000 | 0.93% |
| DAFNA Capital Management LLC | 421,157 | $3,041,000 | 0.79% |
| Sio Capital Management, LLC | 315,564 | $2,278,000 | 0.75% |
| TCG Crossover Management, LLC | 229,100 | $1,654,000 | 0.66% |
| Altium Capital Management LP | 253,000 | $1,827,000 | 0.61% |